Snapshot from Jun 25, 2026 at 22:38 UTC. For live data and tracking: View Live
Entities / Companies / Klinge Biopharma GmbH
Entity

Klinge Biopharma GmbH

Tracked across 1 events · 7 articles · First seen Jun 04, 2026 · Last active Jun 04, 2026

Sentiment
50
Attention
4
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
4 50
Business
Teva launches AHZANTIVE biosimilar in Europe
Sun Pharma announced the launch of AHZANTIVE (aflibercept), a biosimilar to Eylea, in Europe. This launch, which began in May 2026 across markets including France, Germany, Spain, and The Netherlands, strengthens Teva's biosimilars portfolio and…
Impact: Klinge Biopharma GmbH has a semi-exclusive commercialization agreement with Sun Pharma for AHZANTIVE in major parts of Europe and Israel.
Jun 04, 2026 · 7 articles
Key Actions (1)
60 Sun Pharma signed commercialization agreement Klinge Biopharma GmbHTeva launches AHZANTIVE...
NEWSDESK
Track Klinge Biopharma GmbH live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.